← Dashboard StockDuty Jun 20, 2026 06:04 PM ET
CatalystFDA/Bio

PRECIGEN (PGEN) SECURES FDA ORPHAN DRUG EXCLUSIVITY FOR PAPZIMEOS — via YAHOO

Orphan Drug Exclusivity is a significant regulatory catalyst for Precigen's Papzimeos.

What changed
PRECIGEN (PGEN) SECURES FDA ORPHAN DRUG EXCLUSIVITY FOR PAPZIMEOS — via YAHOO
Why it matters
Orphan Drug Exclusivity is a significant regulatory catalyst for Precigen's Papzimeos.
Sources
yahoo
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →IONIS PHARMACEUTICALS, INC. (IONS) DISCUSSES FDA APPROVAL OF TRYNGOLZA FOR SEVERE HYPERTRIGLYCERIDEMIA AND ACUTE PANCREA →
stockduty.xyz · @StockDuty